Literature DB >> 26148656

Hepatitis viruses exploitation of host DNA methyltransferases functions.

Valerio Pazienza1, Concetta Panebianco2, Angelo Andriulli2.   

Abstract

Hepatitis B virus (HBV), hepatitis C virus (HCV) and Delta (HDV) infections are a global health burden. With different routes of infection and biology, HBV, HCV and HDV are capable to induce liver cirrhosis and cancer by impinging on epigenetic mechanisms altering host cell's pathways. In the present manuscript, we reviewed the published studies taking into account the relationship between the hepatitis viruses and the DNA methyltransferases proteins.

Entities:  

Keywords:  DNMTs; Epigenetics; Hepatitis viruses; Interferon

Mesh:

Substances:

Year:  2015        PMID: 26148656     DOI: 10.1007/s10238-015-0372-3

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  116 in total

Review 1.  Hepatocellular carcinoma: present status and future prospects.

Authors:  Josep M Llovet; Michel Beaugrand
Journal:  J Hepatol       Date:  2003       Impact factor: 25.083

Review 2.  The host immune response may be responsible for selection of envelope and precore/core variants of HBV.

Authors:  H C Thomas; W F Carman
Journal:  Prog Liver Dis       Date:  1992

3.  Dnmt3L antagonizes DNA methylation at bivalent promoters and favors DNA methylation at gene bodies in ESCs.

Authors:  Francesco Neri; Anna Krepelova; Danny Incarnato; Mara Maldotti; Caterina Parlato; Federico Galvagni; Filomena Matarese; Hendrik G Stunnenberg; Salvatore Oliviero
Journal:  Cell       Date:  2013-09-26       Impact factor: 41.582

4.  Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein.

Authors:  In Young Park; Bo Hwa Sohn; Eunsil Yu; Dong Jin Suh; Young-Hwa Chung; Je-Ho Lee; Stefan J Surzycki; Young Ik Lee
Journal:  Gastroenterology       Date:  2007-01-25       Impact factor: 22.682

5.  Epigenetic suppression of the TGF-beta pathway revealed by transcriptome profiling in ovarian cancer.

Authors:  Noriomi Matsumura; Zhiqing Huang; Seiichi Mori; Tsukasa Baba; Shingo Fujii; Ikuo Konishi; Edwin S Iversen; Andrew Berchuck; Susan K Murphy
Journal:  Genome Res       Date:  2010-12-14       Impact factor: 9.043

Review 6.  CpG island methylation in precursors of gastrointestinal malignancies.

Authors:  Annie On On Chan; Asif Rashid
Journal:  Curr Mol Med       Date:  2006-06       Impact factor: 2.222

7.  In vitro antiviral activity of SCH446211 (SCH6), a novel inhibitor of the hepatitis C virus NS3 serine protease.

Authors:  Rong Liu; Karim Abid; John Pichardo; Valerio Pazienza; Paul Ingravallo; Rong Kong; Sony Agrawal; Stephane Bogen; Anil Saksena; Kuo-Chi Cheng; Andrew Prongay; F George Njoroge; Bahige M Baroudy; Francesco Negro
Journal:  J Antimicrob Chemother       Date:  2006-12-05       Impact factor: 5.790

Review 8.  Cytosine methylation and the ecology of intragenomic parasites.

Authors:  J A Yoder; C P Walsh; T H Bestor
Journal:  Trends Genet       Date:  1997-08       Impact factor: 11.639

9.  Surveillance for acute viral hepatitis--United States, 2006.

Authors:  Annemarie Wasley; Scott Grytdal; Kathleen Gallagher
Journal:  MMWR Surveill Summ       Date:  2008-03-21

10.  Methylation profile of single hepatocytes derived from hepatitis B virus-related hepatocellular carcinoma.

Authors:  Ran Tao; Jun Li; Jiaojiao Xin; Jian Wu; Jing Guo; Liyuan Zhang; Longyan Jiang; Wu Zhang; Zhe Yang; Lanjuan Li
Journal:  PLoS One       Date:  2011-05-23       Impact factor: 3.240

View more
  2 in total

Review 1.  DNA Methyltransferases: From Evolution to Clinical Applications.

Authors:  Victor M Del Castillo Falconi; Karla Torres-Arciga; Genaro Matus-Ortega; José Díaz-Chávez; Luis A Herrera
Journal:  Int J Mol Sci       Date:  2022-08-12       Impact factor: 6.208

2.  Upregulation of DARS2 by HBV promotes hepatocarcinogenesis through the miR-30e-5p/MAPK/NFAT5 pathway.

Authors:  Xian Qin; Changsheng Li; Tao Guo; Jing Chen; Hai-Tao Wang; Yi-Tao Wang; Yu-Sha Xiao; Jun Li; Pengpeng Liu; Zhi-Su Liu; Quan-Yan Liu
Journal:  J Exp Clin Cancer Res       Date:  2017-10-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.